<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Evaluation of anticancer activities of christia obcordata (stripped butterfly wing) on breast cancer</title>
  </titleInfo>
  <name type="personal">
    <namePart>Nursyaemah Binti Othman</namePart>
    <role>
      <roleTerm authority="marcrelator" type="text">creator</roleTerm>
    </role>
    <role>
      <roleTerm type="text">author.</roleTerm>
    </role>
  </name>
  <typeOfResource manuscript="yes">text</typeOfResource>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">my</placeTerm>
    </place>
    <dateIssued encoding="marc">2025</dateIssued>
    <copyrightDate encoding="marc">2025</copyrightDate>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <form authority="marcform">electronic</form>
    <extent>xii, 61 pages : illustrations ;</extent>
  </physicalDescription>
  <abstract>Anticancer research has advanced significantly in recent decades, with several  new anticancer medicines currently been authorized. The advancement of cancer  treatment can lead to the discovery of new therapies which are capable to maintain  momentum. The purpose of this study was to evaluate the anticancer properties of  Christia obcordata (Stripped Butterfly Wing) against breast cancer. It began with the  collection and preparation of a Christia obcordata sample, which was then subjected to  maceration extraction in triplicate to achieve total extraction of the extracts. Next,  solvent-solvent extraction was performed to get methanol and hexane extracts of Christia  obcordata, which were subsequently analysed using GC-MS to identify bioactive  components. As a vital procedure, the breast cancer cell line (MCF-7) was cultivated in  an incubator until it reached 80 to 90 percent confluency. Furthermore, cell proliferation  assays and morphological analyses were performed and monitored over a three-day  incubation period. For optimization assay, various concentrations of both extracts have  been evaluated to determine the best concentration able to inhibit cancer growth. Extracts  of methanol and hexane at 200 μg/mL yielded positive results. In conclusion, methanolic  extracts of Christia obcordata at a concentration of 200 μg/mL yielded positive findings  across three analyses.</abstract>
  <targetAudience authority="marctarget">specialized</targetAudience>
  <note type="statement of responsibility">Nursyaemah Binti Othman</note>
  <note>Faculty of Industrial Sciences and Technology</note>
  <note>Final Year Report (Bachelor of Applied Science in Industrial Biotechnology) -- Universiti Malaysia Pahang Al-Sultan Abdullah - 2025</note>
  <note>Include bibliographical reference</note>
  <subject authority="lcsh">
    <name type="corporate">
      <namePart>Faculty of Industrial Sciences and Technology</namePart>
    </name>
    <topic>Dissertations</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Universities and colleges</topic>
    <topic>Dissertations</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Final Year Report</topic>
    <topic>Dissertations</topic>
  </subject>
  <identifier type="isbn">THE0010318 (Local)</identifier>
  <identifier type="uri">http://umpir.ump.edu.my/id/eprint/45696</identifier>
  <location>
    <url>http://umpir.ump.edu.my/id/eprint/45696</url>
  </location>
  <recordInfo>
    <recordContentSource authority="marcorg">UMPSA</recordContentSource>
    <recordCreationDate encoding="marc">260126</recordCreationDate>
    <recordChangeDate encoding="iso8601">20260126160909.0</recordChangeDate>
    <languageOfCataloging>
      <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
    </languageOfCataloging>
  </recordInfo>
</mods>
